Literature DB >> 15038916

Pharmacogenetics and psychiatry.

Amlan Basu1, Eva Tsapakis, Kathy Aitchison.   

Abstract

Genetic factors play a significant role in predicting an individual's response to a drug. The response may be the desired therapeutic effect of the drug and also may be the undesirable development of adverse effects. This relationship between genes and drug response interests the pharmacogeneticist. This article aims to give an overview of the exciting discoveries made so far in the field of psychiatry, particularly concerning the response to antidepressants and antipsychotics, as well as to mention some of the more recent findings. The ultimate goal of pharmacogenetics is to provide medication "tailored" to the individual based on their genetic profile, and although this may currently seem a distant target, it has already begun to raise ethical questions, which also are discussed.

Mesh:

Substances:

Year:  2004        PMID: 15038916     DOI: 10.1007/s11920-004-0053-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  49 in total

Review 1.  The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis.

Authors:  K J Aitchison; B D Jordan; T Sharma
Journal:  Drug Metabol Drug Interact       Date:  2000

2.  5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.

Authors:  Vicki L Ellingrod; Paul J Perry; Brian C Lund; Kristy Bever-Stille; Frank Fleming; Timothy L Holman; Del Miller
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

3.  Pharmacogenetics: ethical issues and policy options.

Authors:  Allen Buchanan; Andrea Califano; Jeffrey Kahn; Elizabeth McPherson; John Robertson; Baruch Brody
Journal:  Kennedy Inst Ethics J       Date:  2002-03

4.  Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene.

Authors:  M Schäfer; D Rujescu; I Giegling; A Guntermann; A Erfurth; B Bondy; H J Möller
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

5.  The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.

Authors:  G Chen; W Z Zeng; P X Yuan; L D Huang; Y M Jiang; Z H Zhao; H K Manji
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

6.  Serotonin transporter gene polymorphism and antidepressant response.

Authors:  D K Kim; S W Lim; S Lee; S E Sohn; S Kim; C G Hahn; B J Carroll
Journal:  Neuroreport       Date:  2000-01-17       Impact factor: 1.837

7.  5-HT1A receptor function in depression: effect of chronic amitriptyline treatment.

Authors:  K P Lesch; J Disselkamp-Tietze; A Schmidtke
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 8.  Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

Authors:  H K Manji; G J Moore; G Chen
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

9.  Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.

Authors:  K Atkin; F Kendall; D Gould; H Freeman; J Liberman; D O'Sullivan
Journal:  Br J Psychiatry       Date:  1996-10       Impact factor: 9.319

10.  Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.

Authors:  Bernard Lerer; Ronnen H Segman; Heiner Fangerau; Ann K Daly; Vincenzo S Basile; Roberto Cavallaro; Harald N Aschauer; Robin G McCreadie; Stephanie Ohlraun; Nicol Ferrier; Mario Masellis; Massimiliano Verga; Joachim Scharfetter; Marcella Rietschel; Roger Lovlie; Uriel Heresco Levy; Herbert Y Meltzer; James L Kennedy; Vidar M Steen; Fabio Macciardi
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

View more
  2 in total

1.  Pharmacologic treatment of first-episode schizophrenia: a review of the literature.

Authors:  Shibu P Thomas; Harpal Sing Nandhra; Swaran P Singh
Journal:  Prim Care Companion CNS Disord       Date:  2012-01-05

2.  The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: effects on behavior.

Authors:  Georgia Balsevich; Christian Namendorf; Tamara Gerlach; Manfred Uhr; Mathias V Schmidt
Journal:  Front Behav Neurosci       Date:  2015-01-06       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.